Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macrolides and bronchiectasis: clinical benefit with a resistance price.

× No keyword cloud information.

5 in total

1. Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.

Authors: Laura J Sherrard; Kathryn A Graham; Stef J McGrath; Leanne McIlreavey; Joseph Hatch; Marianne S Muhlebach; Matthew C Wolfgang; Deirdre F Gilpin; J Stuart Elborn; Thamarai Schneiders; Michael M Tunney
Journal: J Antimicrob Chemother Date: 2013-05-21 Impact factor: 5.790

2. Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study.

Authors: Xavier Puéchal; Emmanuelle Génin; Thierry Bienvenu; Claire Le Jeunne; Daniel J Dusser
Journal: PLoS One Date: 2014-10-13 Impact factor: 3.240

3. Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.

Authors: Helene E Kobbernagel; Frederik F Buchvald; Eric G Haarman; Carmen Casaulta; Samuel A Collins; Claire Hogg; Claudia E Kuehni; Jane S Lucas; Heymut Omran; Alexandra L Quittner; Claudius Werner; Kim G Nielsen
Journal: BMC Pulm Med Date: 2016-07-22 Impact factor: 3.317

Review 4. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review.

Authors: Adam J Shapiro; Maimoona A Zariwala; Thomas Ferkol; Stephanie D Davis; Scott D Sagel; Sharon D Dell; Margaret Rosenfeld; Kenneth N Olivier; Carlos Milla; Sam J Daniel; Adam J Kimple; Michele Manion; Michael R Knowles; Margaret W Leigh
Journal: Pediatr Pulmonol Date: 2015-09-29

Review 5. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.

Authors: Rajiv Dhand
Journal: J Aerosol Med Pulm Drug Deliv Date: 2017-10-27 Impact factor: 2.849

5 in total